Traders Watch list: Biocept, Inc. (BIOC), Sprouts Farmers Market, Inc. (SFM), Two Harbors Investment Corp. (TWO)

Biocept, Inc. (BIOC) saw its value decrease by -0.47% as the stock dropped $-0.01 to finish the day at a closing price of $2.1. The stock was lighter in trading and has fluctuated between $0.74-$5.64 per share for the past year. The shares, which traded within a range of $2.01 to $2.25 during the day, are up by 143.34% in the past three months and up by 296.23% over the past six months. It is currently trading 25.94% above its 20 day moving average and 60.59% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 62.05.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

Sprouts Farmers Market, Inc. (SFM) shares were down in last trading by -0.48% to $18.8. It experienced lighter than average volume on day. The stock increased in value by almost 3.81% over the past week and fell -7.02% in the past month. It is currently trading -4.03% below its 50 day moving average and -13.78% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -37.33% decrease in value from its one year high of $30. The RSI indicator value of 45.66, lead us to believe that it is a hold for now.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Two Harbors Investment Corp. (TWO) traded within a range of $8.86 to $9.02 after opening the day at $8.93. The company has seen its stock increase in value by 3.44% so far this year. The stock was up close to 0.89% on light volume in last trading session and closed at $9.02 per share. After the recent gain, the stock is currently holding 0.22% above its 52 week high of $9.18 and 38.36% above its 12-month low of $7.45. The shares are up by over 11.38% in the last three months, and the RSI indicator value of 69.16 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Two Harbors Investment Corp. operates as a real estate investment trust (REIT) that focuses on investing in, financing, and managing residential mortgage-backed securities (RMBS), residential mortgage loans, mortgage servicing rights, commercial real estate and other financial assets. The company’s target assets include agency RMBS collateralized by fixed rate mortgage loans, adjustable rate mortgage loans, hybrid mortgage loans, or derivatives; and non-agency RMBS collateralized by prime mortgage loans, Alt-A mortgage loans, pay-option ARM mortgage loans, and subprime mortgage loans. Its target assets also comprise prime nonconforming and credit sensitive residential mortgage loans; floating and fixed rate commercial real estate loans; CMBS collateralized by commercial real estate loans; and other assets, such as asset backed securities and certain non-hedging transactions. The company qualifies as a REIT for federal income tax purposes. As a REIT, the company would not be subject to federal income tax, if it distributes at least 90% of net taxable income to its stockholders. Two Harbors Investment Corp. was incorporated in 2009 and is headquartered in New York, New York.

 

Stocks on the Move: ACADIA Pharmaceuticals Inc. (ACAD), Agenus Inc. (AGEN), Pulmatrix, Inc. (PULM)

ACADIA Pharmaceuticals Inc. (ACAD) failed to extend gains with the stock declining -0.55% or $-0.22 to close the day at $39.47 on light trading volume of 2.24M shares, compared to its three month average trading volume of 2.4M. The San Diego California 92130 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 91.42%, compared to the industry which has advanced 0.95% over the same period. With RSI of 73.99, the stock should still continue to rise and get closer to its one year target estimate of $42.25, making it a hold for now.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer’s disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Agenus Inc. (AGEN) climbed 1.59% during last trading as the stock added $0.07 to finish the day at $4.47 with about 2.24M shares changing hands, compared to its three month average trading volume of 1.11M. The $384.15M market cap company, which fluctuated between $4.35 and $4.65 during the day, currently situated 68.68% above its 52 week low of $2.65 and -40.32% away from its one year high of $7.49. The RSI of 64.29 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a heat shock protein-based autologous vaccine, which has completed Phase II clinical trials for the treatment of glioblastoma; and QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The company’s preclinical development products include AutoSynVax, a neo-antigen based vaccine targeting the neo-epitope landscape in cancer patients; PhosphoSynVax, a vaccine candidate designed to induce immunity against a novel class of tumor specific neo-epitopes; and checkpoint modulator product candidates targeting GITR, OX40, CTLA-4, LAG-3, TIM-3, PD-1, CEACAM1, and other undisclosed targets. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Pulmatrix, Inc. (PULM) saw its value increase by 0.24% as the stock gained $0.01 to finish the day at a closing price of $4.11. The stock was lighter in trading and has fluctuated between $0.5-$6.98 per share for the past year. The shares, which traded within a range of $4.05 to $4.44 during the day, are up by 351.65% in the past three months and up by 115.18% over the past six months. It is currently trading 30.79% above its 20 day moving average and 149.32% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $15 a share over the next twelve months. The current relative strength index (RSI) reading is 60.06. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology. The company’s proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease. The company has collaboration with Capsugel to develop inhaled therapeutics to treat serious pulmonary diseases. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.

 

Stocks Alert: Tenax Therapeutics, Inc. (TENX), First Bancorp (FBP), Civeo Corporation (CVEO)

Tenax Therapeutics, Inc. (TENX) grew with the stock adding 8.62% or $0.06 to close at $0.74 on active trading volume of 2.24M compared its three months average trading volume of 1.25M. The Morrisville North Carolina 27560 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -69.35% down for the period and down by -62.12% so far this year. With price target of $9.25 and a 77.98% rebound from 52-week low, Tenax Therapeutics, Inc. has plenty of upside potential, making it a hold with a view buy.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company offers Wundecyte, a wound-healing gel. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

First Bancorp (FBP) gained $0.04 to close the day at a new closing price of $6.6, a 0.61% increase in value from its previous closing price that moved the stock 197.3% above its 52 week low of $2.22. A total of 2.24M shares exchanged hands during the day compared with its three month average trading volume of 1.95M. The stock, which fluctuated between $6.57 and $6.66 during the day, currently situated -6.38% below its 52 week high. The stock is up by 2.17% in the past one month and up by 3.77% over the past three months. With a one year target estimate of $7.58 and RSI of 48.74, the stock still has upside potential, making it a hold for now.

First BanCorp. operates as the bank holding company for FirstBank Puerto Rico that provides a range of financial products and services to retail, commercial, and institutional clients. Its Commercial and Corporate Banking segment offers commercial real estate and construction loans, and floor plan financings; and cash and business management services, as well as underwrites municipal securities and provides financial advisory services. The company’s Consumer (Retail) Banking segment offers auto, boat, and personal loans; credit cards; lines of credit; and deposit products comprising interest bearing and non-interest bearing checking and savings accounts, individual retirement accounts, and retail certificates of deposit, as well as engages in the finance leasing and insurance activities. Its Mortgage Banking segment is involved in the origination, sale, securitization, and servicing of various residential mortgage loan products and related hedging activities; acquisition and sale of mortgages in the secondary markets; and provision of mortgage loans purchased from other local banks and mortgage bankers. The company’s Treasury and Investments segment engages in the treasury and investment management activities, such as funding and liquidity management. Its United States Operations segment offers checking, savings, and money market accounts; and residential mortgages, home equity loans, lines of credit, and automobile loans, as well as retail certificates of deposits, Internet banking services, remote data capture, automated clearing house transactions, and commercial real estate products. The company’s Virgin Islands Operations segment is involved in the consumer, commercial lending, and deposit-taking activities. As of December 31, 2015, it operated 51 branches in Puerto Rico, 11 branches in the U.S. Virgin Islands and British Virgin Islands, and 10 branches in the state of Florida. The company was founded in 1948 and is headquartered in Santurce, Puerto Rico.

Civeo Corporation (CVEO) shares were up in last trading by 1.87% to $3.26. It experienced higher than average volume on day. The stock increased in value by almost 7.59% over the past week and grew 26.36% in the past month. It is currently trading 23.39% above its 50 day moving average and 79.71% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -11.89% decrease in value from its one year high of $3.7. The RSI indicator value of 60.93, lead us to believe that it is a hold for now.

Civeo Corporation provides remote site accommodation, logistics, and facility management services to the natural resource industry in Australia, Canada, and the United States. The company develops lodges and villages, open camps, and mobile assets, including modular, skid-mounted accommodation, and central facilities that provide long-term and temporary work force accommodations. It also provides catering and food services, housekeeping, laundry, water and wastewater treatment, power generation, communications, and personnel logistics services, as well as sewage hauling services. The company operates 19 lodges and villages with approximately 23,000 rooms in Canada and Australia; 9 smaller open camp properties; and a fleet of mobile accommodation assets. It serves independent oil and natural gas companies, mining companies, and oilfield and mining service companies. The company is headquartered in Houston, Texas.

 

Stocks Intraday Alert: CEL-SCI Corporation (CVM), Sears Holdings Corporation (SHLD), Leucadia National Corporation (LUK)

CEL-SCI Corporation (CVM) managed to rebound with the stock declining -0.08% or $0 to close the day at $0.13 on lower than average trading volume of 2.23M shares, compared to its three month average trading volume of 2.76M. The Vienna Virginia 22182 based company has been outperforming the biotechnology companies by -55.2562% for last three months and its recent losses have trimmed gains to 85.57% YTD, versus the biotechnology industry which is up 0.44% for the same period. The RSI of 55.4 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Sears Holdings Corporation (SHLD) had a active trading with around 2.22M shares changing hands compared to its three month average trading volume of 1.71M. The stock traded between $7.01 and $7.62 before closing at the price of $7.58 with 6.76% change on the day. The Hoffman Estates Illinois 60179 based company is currently trading 37.82% above its 52 week low of $5.5 and -60.36% below its 52 week high of $19.12. Both the RSI indicator and target price of 49.61 and $9 respectively, lead us to believe that it should be put on hold over the coming weeks.

Sears Holdings Corporation operates as a retailer in the United States. It operates in two segments, Kmart and Sears Domestic. The Kmart segment operates retail stores that offer a range of products, including consumer electronics, seasonal merchandise, outdoor living, toys, lawn and garden equipment, food and consumables, and apparel; and in-store pharmacies. It provides merchandise under the Jaclyn Smith, Joe Boxer, and Alphaline labels; Sears brand products, such as Kenmore, Craftsman, and DieHard; and Kenmore-branded products. As of October 31, 2015, this segment operated approximately 952 Kmart stores. The Sears Domestic segment operates stores that provide appliances, consumer electronics/connected solutions, tools, sporting goods, outdoor living, lawn and garden equipment, apparel, footwear, jewelry, and accessories, as well as automotive services and products, such as tires, batteries, and home fashion products. It also offers appliances and services to commercial customers in the single-family residential construction/remodel, property management, multi-family new construction, and government/military sectors; appliance and plumbing fixtures to architects, designers, and new construction or remodeling customers; parts and repair services for appliances, lawn and garden equipment, consumer electronics, floor care products, and heating and cooling systems; and home improvement services, as well as protection agreements and product installation services. This segment provides merchandise under the Kenmore, Craftsman, DieHard, Covington, Canyon River Blues, Metaphor, Outdoor Life, Structure, and Apostrophe brands, as well as under the Roadhandler, Ty Pennington Style, and Alphaline brands. As of October 31, 2015, this segment operated 735 Sears stores. Sears Holdings Corporation was founded in 1899 and is based in Hoffman Estates, Illinois.

Leucadia National Corporation (LUK) traded within a range of $24.74 to $25.02 after opening the day at $25. The company has seen its stock increase in value by 7.53% so far this year. The stock was up close to 0.36% on active volume in last trading session and closed at $25 per share. After the recent gain, the stock is currently holding 0.24% above its 52 week high of $25.02 and 77.6% above its 12-month low of $14.27. The shares are up by over 20.74% in the last three months, and the RSI indicator value of 64 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Leucadia National Corporation, a diversified holding company, engages in investment banking and capital markets, beef processing, manufacturing, oil and gas exploration and production, and asset management activities. Its services include equities research, sales, and trading; financing, securities lending, and other brokerage; wealth management; fixed income sales and trading; trade execution in foreign exchange, spot, forward, swap, and option contracts across currencies; equity and debt capital markets, as well as financial advisory in the areas of mergers and acquisition, restructuring, and recapitalization; equity and debt financing to companies, financial sponsors, and government entities; and investment management services to pension funds, insurance companies, and other institutional investors. The company also provides investment advisory, portfolio management, and operational services to accredited investors and qualified purchasers; and online foreign exchange trading and related services. In addition, it develops and owns residential and mixed-use real estate properties in California, New York, Florida, Virginia, South Carolina, and Maine; provides capital solutions, investment sales advisory, research, and services for multifamily and commercial properties; and purchases automobile installment contracts, as well as leases used Harley-Davidson motorcycles. Further, it processes and markets beef, beef by-products, pork, and leather; owns oil and gas properties in the Bakken field, as well as leases and develops oil and gas properties in Texas and Oklahoma; owns and operates 27 automobile dealerships; offers fixed wireless broadband services in Italy; manufactures and markets plastic netting and wood products; and mines gold and silver ores. The company was formerly known as Talcott National Corp. and changed its name to Leucadia National Corporation in June 1980. Leucadia National Corporation was founded in 1968 and is headquartered in New York, New York.

 

Stocks Under Review: XPO Logistics, Inc. (XPO), Opexa Therapeutics, Inc. (OPXA), Glu Mobile Inc. (GLUU)

XPO Logistics, Inc. (XPO) continued its upward trend with the stock climbing 2.91% or $1.43 to close the day at $50.49 on active trading volume of 2.17M shares, compared to its three month average trading volume of 1.16M. The Greenwich Connecticut 06831 based company has been outperforming the air delivery & freight services group over the past 52 weeks, with the stock gaining 95.17%, compared to the industry which has advanced 23.03% over the same period. With RSI of 68.99, the stock should still continue to rise and get closer to its one year target estimate of $53.06, making it a hold for now.

XPO Logistics, Inc. provides transportation and logistics services primarily in the United States. The company’s Transportation segment provides freight brokerage, last mile, expedite, intermodal, less-than truckload, truckload, and forwarding services; and time-critical, time-sensitive, or high priority freight shipment services. Its Logistics segment offers contract logistics services, including value-added warehousing and distribution, reverse logistics, transportation management, freight bill audit and payment, lean manufacturing support, aftermarket support, and supply chain optimization solutions to corporations and government agencies. The company provides services to customers in various industries, such as high tech, retail, e-commerce, manufacturing, telecommunications, aerospace and defense, life sciences, healthcare, medical equipment, agriculture, and food and beverage. XPO Logistics, Inc. was founded in 1996 and is headquartered in Greenwich, Connecticut.

Opexa Therapeutics, Inc. (OPXA) retreated with the stock falling -1.8% or $-0.02 to close at $1.09 on active trading volume of 2.16M compared its three months average trading volume of 1.34M. The The Woodlands Texas 77381 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -47.09% down for the period and up by 18.48% so far this year. With price target of $4.33 and a 118% rebound from 52-week low, Opexa Therapeutics, Inc. has plenty of upside potential, making it a hold with a view buy.

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company’s lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is based in The Woodlands, Texas.

Glu Mobile Inc. (GLUU) managed to rebound with the stock declining 0% or $0 to close the day at $2.12 on lower than average trading volume of 2.15M shares, compared to its three month average trading volume of 3.2M. The San Francisco California 94105 based company has been outperforming the multimedia & graphics software companies by 0.78% for last three months and its recent gains have pushed the stock slightly up 9.28% YTD, versus the multimedia & graphics software industry which is up 18.6% for the same period. The RSI of 40.68 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, celebrity, sports, and simulation genre mobile games. It creates games based on its own brands, including Contract Killer, Cooking Dash, Deer Hunter, Diner Dash, Eternity Warriors, Frontline Commando, Gun Bros, Heroes of Destiny, Racing Rivals, Tap Sports Baseball, and Tap Sports Football. The company also creates games based on third-party licensed brands, such as Kim Kardashian: Hollywood, Kendall and Kylie, Katy Perry Pop, James Bond: World of Espionage, Mission Impossible: Rogue Nation, and Sniper X With Jason Statham. Glu Mobile Inc. markets, sells, and distributes its games primarily through direct-to-consumer digital storefronts worldwide. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 2005. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Francisco, California.

 

Stocks Trending Alert: Tableau Software, Inc. (DATA), Tahoe Resources Inc. (TAHO), Galena Biopharma, Inc. (GALE)

Tableau Software, Inc. (DATA) saw its value increase by 1.72% as the stock gained $0.93 to finish the day at a closing price of $55.01. The stock was higher in trading and has fluctuated between $39.07-$62.53 per share for the past year. The shares, which traded within a range of $53.86 to $55.2 during the day, are up by 19.59% in the past three months and up by 1.4% over the past six months. It is currently trading 10.64% above its 20 day moving average and 18.71% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $57.74 a share over the next twelve months. The current relative strength index (RSI) reading is 76.53.The technical indicator do not lead us to believe the stock will see more gains any time soon.

Tableau Software, Inc. provides business analytics software products. It offers Tableau Desktop, a self-service analytics product that empowers people to access and analyze data independently; and Tableau Server, a business intelligence platform with data management, scalability, and security to foster sharing of analytics, as well as to improve the dissemination of information across an organization and promote improved decision-making. The company also provides Tableau Online, a hosted SaaS version of Tableau Server; and Tableau Public, a cloud-based platform that allows users of various backgrounds, such as bloggers, journalists, researchers, and government workers to visualize public data on their Websites. In addition, it offers Vizable, an iOS application that turns data into graphs, as well as allows it to be shared from an iPad; and maintenance and support, training, and professional services. It offers its products and services to organizations in various industries, including business services, energy and telecommunications, financial services, life sciences and healthcare, manufacturing and technology, media and entertainment, public sector, education, retail, consumer, and distribution industries. The company sells its products directly, as well as through indirect sales channels, such as technology vendors, resellers, original equipment manufacturers, and independent software vendor partners in the United States, Australia, Canada, China, France, Germany, India, Ireland, Japan, Singapore, the United Kingdom, and internationally. Tableau Software, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Tahoe Resources Inc. (TAHO) shares were down in last trading by -2.31% to $8.9. It experienced lighter than average volume on day. The stock decreased in value by almost -6.02% over the past week and fell -2.94% in the past month. It is currently trading -4.4% below its 50 day moving average and -27.24% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -47.68% decrease in value from its one year high of $17.01. The RSI indicator value of 46.38, lead us to believe that it is a hold for now.

Tahoe Resources Inc., together with its subsidiaries, explores, develops, and operates mines in the Americas. The company primarily produces copper, gold, silver, lead/zinc, and natural gas and petroleum. It holds interest in the Escobal mine property comprising 29.1 million tons of proven and probable mineral reserves located in southeast Guatemala; La Arena mine property, which consist of 80.3 million tons of proven and probable mineral reserves located in northern Perú; and Shahuindo mine comprising 111.9 million tons of proven and probable mineral reserves located in northern Perú. The company was formerly known as CKM Resources Inc. and changed its name to Tahoe Resources Inc. in January 2010. Tahoe Resources Inc. was incorporated in 2009 and is headquartered in Reno, Nevada.

Galena Biopharma, Inc. (GALE) traded within a range of $0.74 to $0.7879 after opening the day at $0.78. The company has seen its stock decrease in value by -60.43% so far this year. The stock was down close to -2.84% on light volume in last trading session and closed at $0.77 per share. After the recent fall, the stock is currently holding -98.46% below its 52 week high of $49.802 and 6.61% above its 12-month low of $0.72. The shares are down by over -78.32% in the last three months, and the RSI indicator value of 26.42 is bullish. They are not pointing to a rebound in the stock. We should get in as it looks to have found a bottom.

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The company’s lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b clinical trial for investigating a novel vaccination series; and GALE-401 (anagrelide controlled release), which is in a Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy’s Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.

 

Stocks In Queue: Biostage, Inc. (BSTG), GameStop Corp. (GME), First Solar, Inc. (FSLR)

Biostage, Inc. (BSTG) fell -0.1% during last trading as the stock lost $0 to finish the day at $0.31 with about 2.15M shares changing hands, compared to its three month average trading volume of 444.53K. The $9.01M market cap company, which fluctuated between $0.305 and $0.32 during the day, currently situated 6.26% above its 52 week low of $0.2925 and -89.13% away from its one year high of $2.8599. The RSI of 17 indicates the stock is oversold at the current levels, buy for now.

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company’s Cellframe technology combines a proprietary biocompatible scaffold with a patient’s own stem cells to create Cellspan organ implants. The company is developing bioengineered organ implants to treat cancers, infection, trauma, congenital abnormalities, and other life-threatening conditions of the esophagus, bronchus, and trachea. Its implants are being advanced and tested in a preclinical collaborative study with Mayo Clinic. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.

GameStop Corp. (GME) gained $0.04 to close the day at a new closing price of $25.78, a 0.16% increase in value from its previous closing price that moved the stock 30.17% above its 52 week low of $20.1. A total of 2.15M shares exchanged hands during the day compared with its three month average trading volume of 2.45M. The stock, which fluctuated between $25.54 and $26.08 during the day, currently situated -20.35% below its 52 week high. The stock is up by 10.45% in the past one month and up by 13.81% over the past three months. With a one year target estimate of $26.32 and RSI of 63.45, the stock still has upside potential, making it a hold for now.

GameStop Corp. operates as an omnichannel video game retailer. It sells new and pre-owned video game hardware; physical and digital video game software; pre-owned and value video game products; video game accessories, such as controllers, gaming headsets, memory cards, and other add-ons for use with video game hardware and software; and digital products, including downloadable content, network points cards, prepaid digital and subscription cards, and digitally downloadable software. The company also sells mobile and consumer electronics, including smart phones, tablets, headphones, and accessories, as well as pre-owned smart phones; personal computer (PC) entertainment software in various genres, including sports, action, strategy, adventure/role playing, and simulation; and strategy guides, magazines, and gaming-related toys. In addition, it operates electronic commerce Websites comprising gamestop.com, ebgames.com.au, ebgames.co.nz, gamestop.ca, gamestop.it, gamestop.ie, gamestop.de, gamestop.co.uk, thinkgeek.com, and micromania.fr. Further, the company operates kongregate.com, a browser-based game site; Game Informer magazine, a print and digital video game publication; iOS and Android mobile applications; Simply Mac, a certified Apple consumer electronic products reseller; and Spring Mobile, an authorized AT&T reseller operating pre-paid wireless stores under the Cricket Wireless name that offers prepaid services, devices, and accessories. As of January 30, 2016, it operated approximately 7,117 stores in the United States, Australia, Canada, and Europe. GameStop Corp. primarily offers its products under the GameStop, EB Games, and Micromania names. The company, formerly known as GSC Holdings Corp., was founded in 1994 and is headquartered in Grapevine, Texas.

First Solar, Inc. (FSLR) had a light trading with around 2.13M shares changing hands compared to its three month average trading volume of 2.47M. The stock traded between $33.73 and $34.82 before closing at the price of $34.73 with 2.39% change on the day. The Tempe Arizona 85281 based company is currently trading 21.43% above its 52 week low of $28.6 and -53.25% below its 52 week high of $74.29. Both the RSI indicator and target price of 62.84 and $34.1 respectively, lead us to believe that it should be put on hold over the coming weeks.

First Solar, Inc. provides solar energy solutions in the United States and internationally. It operates through two segments, Components and Systems. The Components segment designs, manufactures, and sells solar modules that convert sunlight into electricity. This segment manufactures cadmium telluride and crystalline silicon modules for system integrators and operators. The Systems segment provides turn-key photovoltaic solar power systems or solar solutions, such as project development; engineering, procurement, and construction; and operating and maintenance services to utilities, independent power producers, and commercial and industrial companies. It also commissions a 52.5 megawatt Shams Ma’an solar power plant in the Hashemite Kingdom of Jordan. The company was formerly known as First Solar Holdings, Inc. and changed its name to First Solar, Inc. in 2006. First Solar, Inc. was founded in 1999 and is headquartered in Tempe, Arizona.

 

Trader’s Round Up: Cara Therapeutics, Inc. (CARA), Abraxas Petroleum Corporation (AXAS), Ciena Corporation (CIEN)

Cara Therapeutics, Inc. (CARA) retreated with the stock falling -2.83% or $-0.44 to close at $15.09 on active trading volume of 2.05M compared its three months average trading volume of 1.58M. The Shelton Connecticut 06484 based company operating under the Biotechnology industry has been trending up for the last 52 weeks, with the shares price now 86.99% up for the period and up by 62.43% so far this year. With price target of $21.75 and a 254.23% rebound from 52-week low, Cara Therapeutics, Inc. has plenty of upside potential, making it a hold with a view buy.

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body’s peripheral nervous system. Its lead product candidate includes I.V. CR845, which is in Phase III clinical trials for the treatment acute postoperative pain in adult patients, as well as completed Phase II clinical trials for the treatment of uremic pruritus disease. The company is also developing Oral CR845, which is in Phase IIa clinical trials for the treatment of moderate-to-severe acute and chronic pain; and CR701, which is in preclinical trial stage for treating neuropathic and inflammatory pain. It has licensing agreements with Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize products containing CR845 in South Korea; and Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845 for acute pain and uremic pruritus in Japan. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Shelton, Connecticut.

Abraxas Petroleum Corporation (AXAS) dropped $-0.11 to close the day at a new closing price of $2.29, a -4.58% decrease in value from its previous closing price that moved the stock 182.72% above its 52 week low of $0.81. A total of 2.05M shares exchanged hands during the day compared with its three month average trading volume of 2.1M. The stock, which fluctuated between $2.22 and $2.4 during the day, currently situated -23.41% below its 52 week high. The stock is down by -16.73% in the past one month and up by 29.38% over the past three months. With a one year target estimate of $3.3 and RSI of 39.87, the stock still has upside potential, making it a hold for now.

Abraxas Petroleum Corporation, an independent energy company, engages in the acquisition, exploitation, development, and production of oil and gas properties in the United States. The company operates oil and gas assets in the Rocky Mountain, Permian Basin, and onshore Gulf Coast regions. As of December 31, 2014, its estimated net proved reserves were 43.2 million barrels of oil equivalent. The company was founded in 1977 and is based in San Antonio, Texas.

Ciena Corporation (CIEN) shares were down in last trading by -1.01% to $25.37. It experienced lighter than average volume on day. The stock increased in value by almost 4.75% over the past week and grew 6.96% in the past month. It is currently trading 5.18% above its 50 day moving average and 19.89% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -1.63% decrease in value from its one year high of $25.79. The RSI indicator value of 61.2, lead us to believe that it is a hold for now.

Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. The company’s Networking Platforms segment offers hardware networking solutions optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. Its products include 6500 Packet-Optical Platform and the 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 4200 Advanced Services Platform, Corestream 5100/5200 Advanced Services Platform, Common Photonic Layer, and 6100 Multiservice Optical Platform. This segment also sells operating system software and enhanced software features embedded in each of these products. The company’s Software and Software-Related Services segment offers network management solutions, including the OneControl Unified Management System, ON-Center Network & Service Management Suite, Ethernet Services Manager, Optical Suite Release, and Planet Operate; and Blue Planet network virtualization, service orchestration, and network management software platform, as well as related installation, support, and consulting services. Its Global Services segment provides consulting and network design, installation and deployment, maintenance support, and training services. The company sells its products through direct and indirect sales channels to network operators. Ciena Corporation was founded in 1992 and is headquartered in Hanover, Maryland.

 

Traders Recap: Retail Properties of America, Inc. (RPAI), Conduent Incorporated (CNDT), Enbridge Energy Partners, L.P. (EEP)

Retail Properties of America, Inc. (RPAI) continued its downward trend with the stock declining -0.46% or $-0.07 to close the day at $15.03 on higher than average trading volume of 2.04M shares, compared to its three month average trading volume of 1.53M. The Oak Brook Illinois 60523 based company has been underperforming the reit – retail companies by 0.2473% for last three months and its recent gains have offset losses to -1.96% YTD, versus the reit – retail industry which is down -0.1% for the same period. The RSI of 50.16 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Retail Properties of America, Inc. is a real estate investment trust. It engages in acquisition, development and management of properties. The trust invests in the real estate markets of United States. Its portfolio consists of retail properties, including lifestyle, power, neighborhood, and community centers, in addition to single-user net lease properties. The firm was formerly known as Inland Western Retail Real Estate Trust, Inc. Retail Properties of America, Inc. is based in Oak Brook, Illinois.

Conduent Incorporated (CNDT) had a light trading with around 2.03M shares changing hands compared to its three month average trading volume of 4.54M. The stock traded between $15 and $15.25 before closing at the price of $15.12 with 0.07% change on the day. The Norwalk Connecticut 06856 based company is currently trading 15.42% above its 52 week low of $13.1 and -7.01% below its 52 week high of $16.26. Both the RSI indicator and target price of 59.4 and $15 respectively, lead us to believe that it should be put on hold over the coming weeks.

Conduent Incorporated provides business process services for healthcare, public sector, and commercial industries in the United States. It offers payment integrity, support, member engagement, health risk assessment, claims processing, mailroom, and outbound printing services to healthcare payers; care and quality analytics and software adoption services to hospitals, doctors, and other healthcare providers, including large healthcare systems; medicaid management fiscal agent, pharmacy benefits management, and clinical program management to medicaid programs and federally-funded U.S. government healthcare programs; and inside sales for drug detailing, clinical trial recruitment, patient access and medication adherence, and compliance solutions for pharmaceutical and life science companies. The company also provides support for electronic toll collection, public transit, parking, photo enforcement, and commercial vehicle operations; and support for government benefit programs, such as child support, electronic benefits, eligibility and payment cards, unclaimed property, and others. In addition, it offers customer care, human resource management, and finance and accounting services; industry-specific services comprising personalized product information for clients in the automotive industry; digitized source-to-pay solutions for clients in the manufacturing industry; customer experience and marketing services for clients in the retail industry; mortgage and consumer loan processing for clients in the financial services industry; and customized workforce learning solutions for clients in the aerospace industry. Further, the company engages in the government health enterprise medicaid platform business that implements and maintains systems for health enterprise clients. Conduent Incorporated was founded in 2016 and is based in Basking Ridge, New Jersey. Conduent Incorporated is a subsidiary of Xerox Corporation.

Enbridge Energy Partners, L.P. (EEP) traded within a range of $18.18 to $18.44 after opening the day at $18.37. The company has seen its stock decrease in value by -25.81% so far this year. The stock was up close to 0.38% on active volume in last trading session and closed at $18.35 per share. After the recent gain, the stock is currently holding -27.77% below its 52 week high of $26.37 and 40.95% above its 12-month low of $15.16. The shares are down by over -16.17% in the last three months, and the RSI indicator value of 28.37 is bullish. They are not pointing to a rebound in the stock. We should get in as it looks to have found a bottom.

Enbridge Energy Partners, L.P. owns and operates a diversified portfolio of crude oil and natural gas transportation systems in the United States. It operates through two segments, Liquids and Natural Gas. The Liquids segment operates Lakehead system that consists of interstate common carrier crude oil and liquid petroleum pipeline, and storage assets, which transports crude oil and liquid petroleum from western Canada to the United States. This segment also operates North Dakota crude oil system that consists of approximately 683 miles long, has 23 pump stations, delivery points, and storage facilities with a storage capacity of approximately 1.8 million barrels; and Mid-Continent system, which includes approximately 433 miles of crude oil pipelines and 23.6 million barrels of storage capacity. This segment serves integrated oil companies, independent oil producers, and refiners and marketers. The Natural Gas segment operates natural gas and natural gas liquids (NGL) gathering and transportation pipeline systems, natural gas processing and treating facilities, and NGL fractionation facility, as well as provides trucking, rail, and liquids marketing services in east and north Texas, as well as the Texas Panhandle and western Oklahoma. This segment operates approximately 10,900 miles of natural gas and NGL gathering and transmission pipelines. This segment also offers natural gas supply, transportation, balancing, storage, and sales services. This segment serves natural gas aggregators, wholesale customers, refiners and petrochemical producers, fractionators, propane distributors, and industrial customers, various third parties, and end users. Enbridge Energy Company, Inc. operates as a general partner of Enbridge Energy Partners, L.P. The company was formerly known as Lakehead Pipe Line Partners, L.P. and changed its name to Enbridge Energy Partners, L.P. in 2001. Enbridge Energy Partners, L.P. was founded in 1991 and is headquartered in Houston, Texas.

 

Stocks In Action: Ocwen Financial Corporation (OCN), WisdomTree Investments, Inc. (WETF), Tenet Healthcare Corp. (THC)

Ocwen Financial Corporation (OCN) traded within a range of $5.82 to $5.94 after opening the day at $5.87. The company has seen its stock increase in value by 8.16% so far this year. The stock was down close to -0.17% on light volume in last trading session and closed at $5.83 per share. After the recent fall, the stock is currently holding -9.05% below its 52 week high of $6.41 and 351.94% above its 12-month low of $1.29. The shares are up by over 21.46% in the last three months, and the RSI indicator value of 67.48 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Ocwen Financial Corporation, a financial services holding company, engages in servicing and origination of mortgage loans in the United States. Its Servicing segment provides residential and commercial mortgage loan servicing, special servicing, and asset management services to owners of mortgage loans and foreclosed real estate. This segment’s residential servicing portfolio includes conventional, government insured, and non-agency loans. The company’s Lending segment originates and purchases conventional and government-insured residential forward and reverse mortgage loans primarily through its correspondent lending arrangements, broker relationships, and directly with mortgage customers. Ocwen Financial Corporation was founded in 1988 and is headquartered in West Palm Beach, Florida.

WisdomTree Investments, Inc. (WETF) continued its upward trend with the stock climbing 1.83% or $0.16 to close the day at $8.92 on light trading volume of 2.01M shares, compared to its three month average trading volume of 2.61M. The New York New York 10167 based company has been underperforming the asset management group over the past 52 weeks, with the stock losing -24.85%, compared to the industry which has advanced 32.86% over the same period. With RSI of 33, the stock should still continue to rise and get closer to its one year target estimate of $9.72, making it a hold for now.

WisdomTree Investments, Inc., through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans. It develops index using its fundamentally weighted index methodology. In addition, the company provides investment advisory services. The company was founded in 1985 and is based in New York, New York.

Tenet Healthcare Corp. (THC) gained $0.62 to close the day at a new closing price of $19.86, a 3.22% increase in value from its previous closing price that moved the stock 41.25% above its 52 week low of $14.06. A total of 2.01M shares exchanged hands during the day compared with its three month average trading volume of 2.6M. The stock, which fluctuated between $19.2 and $19.88 during the day, currently situated -41.73% below its 52 week high. The stock is up by 4.58% in the past one month and up by 21.1% over the past three months. With a one year target estimate of $23.69 and RSI of 72.51, the stock still has upside potential, making it a sell for now.

Tenet Healthcare Corp., together with its subsidiaries, primarily operates acute care hospitals and related healthcare facilities. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive, critical, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including open-heart surgery, neonatal intensive care, and neurosciences; quaternary care services for heart, liver, kidney, and bone marrow transplants; quaternary pediatric and burn services; gamma-knife brain surgery; and cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine. In addition, it offers clinical research programs related to cardiovascular and pulmonary diseases, musculoskeletal disorders, neurological disorders, genitourinary diseases, and various cancers, as well as drug and medical device studies. Further, the company operates freestanding ambulatory surgery and imaging centers, short-stay surgical facilities, and Aspen’s hospitals and clinics. Additionally, it offers operational management for patient access, accounts receivable management, health information management, revenue integrity, and patient financial services; communications and engagement solutions; and clinical integration, financial risk management, and population health management services. As of December 31, 2015, the company operated 86 hospitals, 20 short-stay surgical hospitals, and approximately 475 outpatient centers; and 9 private hospitals and clinics, as well as 249 ambulatory surgery, 20 imaging, and 35 urgent care centers in the United Kingdom. Tenet Healthcare Corp. was founded in 1967 and is headquartered in Dallas, Texas.